This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Antidote Therapeutics, Inc., Blink Biomedical, Hennepin Healthcare Research Institute. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1 
1 out of 3 Years Active: 2022
Title: Zuzana Biesova: Innovator in Nicotine-Binding Antibodies
Introduction
Zuzana Biesova is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of novel nicotine-binding antibodies. Her work aims to address nicotine addiction and facilitate smoking cessation.
Latest Patents
Zuzana Biesova holds 1 patent for her innovative work on nicotine-binding antibodies. This patent describes methods for using these antibodies to treat nicotine addiction, assist in smoking cessation, and address nicotine overdose or poisoning.
Career Highlights
Throughout her career, Zuzana has worked with notable companies such as Antidote Therapeutics, Inc. and Blink Biomedical. Her expertise in the field has allowed her to contribute to groundbreaking research and development efforts.
Collaborations
Zuzana has collaborated with esteemed colleagues, including Matthew W. Kalnik and Thomas Thisted. These partnerships have further enhanced her research and innovation in the biomedical sector.
Conclusion
Zuzana Biesova's work in developing nicotine-binding antibodies represents a significant advancement in treating nicotine addiction and related health issues. Her contributions to the field continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile